Skip to main content

Table 3 Wilcoxon sign-rank test was used to test the difference between pre-PP1M and Post-PP1M. Comparison of Direct Cost for patients with ≥ 1 Inpatient Stay in 1 Year Pre-PP1M Treatment with OAPs

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

 

Medicine costs

Hospitalization costs

Direct costs

pre-PP1M (¥)

8992±3414

25,656±18,756

34,700±18,044

Post-PP1M (¥)

21,961±5492

7179±10,552

27,705±8266

Difference

144%

-72.02%

-20.16%

P

< 0.01

< 0.01

< 0.01